Sign In
Buy BIVI
$1.65
-0.0500 (-2.94%)
At Close: Jun 03, 2026
Conagra Brands shares slide as CEO Connolly ousted
07:26am, Monday, 13'th Apr 2026
Shares of Conagra Brands Inc (NYSE:CAG) were down more than 5.6% on Monday after the packaged food company announced that CEO Sean Connolly will step down....
Deutsche Bank cuts RS Group to hold as industrial recovery outlook clouds
05:42am, Monday, 13'th Apr 2026
Shares in RS Group (LSE: RS1), the industrial electronics and maintenance products distributor, fell almost 3% after Deutsche Bank downgraded the stock from...
Shell and BP shares lifted as oil rebounds on breakdown of US-Iran peace talks
04:31am, Monday, 13'th Apr 2026
Shell PLC (LSE:SHEL, NYSE:SHEL) and BP PLC (LSE:BP.) shares moved higher at the start of the week, outperforming a weaker wider market as oil prices surged...
BioVie CEO explains Bezisterim Parkinson's trial results - ICYMI
11:46am, Saturday, 11'th Apr 2026
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) earlier this week outlined its evolving approach to Parkinson's disease, with CEO Cuong Do highlighting the company's focus on neuroinflammation and insulin resi
BioVie CEO explains Bezisterim Parkinson’s trial results - ICYMI
07:27am, Saturday, 11'th Apr 2026
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) earlier this week outlined its evolving approach to Parkinson’s disease, with CEO Cuong Do highlighting the company’s...
BioVie targets Parkinson's at its source with lead drug bezisterim
11:02am, Thursday, 26'th Mar 2026
For decades, treatment of Parkinson's disease has centered on replacing dopamine, the neurotransmitter whose decline drives the disease's hallmark motor symptoms. But while therapies such as levodopa
BioVie targets Parkinson’s at its source with lead drug bezisterim
07:00am, Thursday, 26'th Mar 2026
For decades, treatment of Parkinson’s disease has centered on replacing dopamine, the neurotransmitter whose decline drives the disease’s hallmark motor...
Nasdaq, S&P 500 in the red as investors digest slower GDP and steady inflation
12:05pm, Friday, 13'th Mar 2026
4:05pm: In the red US stocks remained under pressure on Friday afternoon as investors reacted to new data indicating slowing economic growth amid the...
Dow slides as oil prices hit triple digits amid Iran tensions
12:20pm, Thursday, 12'th Mar 2026
4:15pm: Tech stocks take hit Wall Street plunged Thursday as Middle East tensions sent oil soaring past $100 a barrel, stoking fears of a wider conflict and...
BioVie to present Parkinson's study data at AD/PD 2026 conference
09:08am, Thursday, 12'th Mar 2026
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that an abstract from its SUNRISE-PD study evaluating its lead candidate bezisterim (NE3107) for Parkinson's disease has been accepted for presentatio
UiPath margins shine as AI fuels growth
07:25am, Thursday, 12'th Mar 2026
UiPath Inc (NYSE:PATH) reported stronger-than-expected fourth-quarter results driven by healthy subscription growth and rising profitability. The automation...
BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript
Roku shares rise on strong fourth quarter earnings beat
06:32am, Friday, 13'th Feb 2026
Roku Inc (NASDAQ:ROKU) shares climbed almost 5% following the company’s release of fourth quarter 2025 results, which exceeded Wall Street expectations and...
Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights
12:12pm, Thursday, 12'th Feb 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your right
BioVie highlights bezisterim research at ACP meeting
08:35am, Thursday, 12'th Feb 2026
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said on Thursday that two abstracts highlighting research on its lead drug candidate bezisterim (NE3107) have been accepted for presentation at the 2026 American
